We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Healthcare | 14.21% |
| 3 | Technology | 14.12% |
| 4 | Consumer Staples | 9.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENH
126
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $23.4M | 0.18% |
348,101
+82,437
| +31% | +$5.4M |
|
|
DD
127
DELISTED
Du Pont De Nemours E I
DD
| $23.4M | 0.18% |
360,475
+21,904
| +6% | +$1.44M |
|
|
WBK
128
DELISTED
Westpac Banking Corporation
WBK
| $23.3M | 0.18% |
1,056,649
-64,388
| -6% | -$1.44M |
|
129
Infosys
INFY
$51B
| $23.3M | 0.18% |
2,605,408
+234,380
| +10% | +$2.19M |
|
130
Wipro
WIT
$19.5B
| $23.2M | 0.18% |
10,020,336
+2,140,752
| +27% | +$4.89M |
|
131
Becton Dickinson
BDX
$46.4B
| $23.1M | 0.18% |
139,758
-10,775
| -7% | -$1.72M |
|
|
SHPG
132
DELISTED
Shire pic
SHPG
| $23.1M | 0.18% |
125,492
+56,905
| +83% | +$10.3M |
|
133
DuPont de Nemours
DD
$18.6B
| $23.1M | 0.18% |
183,501
+7,959
| +5% | +$1.05M |
|
134
Teva Pharmaceuticals
TEVA
$40.4B
| $22.8M | 0.18% |
454,484
+17,510
| +4% | +$932K |
|
|
UN
135
DELISTED
Unilever NV New York Registry Shares
UN
| $22.7M | 0.18% |
484,059
+21,571
| +5% | +$967K |
|
136
American Electric Power
AEP
$70.4B
| $22.6M | 0.18% |
322,307
+18,040
| +6% | +$1.18M |
|
137
AB InBev
BUD
$164B
| $22.5M | 0.18% |
171,058
+2,421
| +1% | +$305K |
|
138
Kraft Heinz
KHC
$32.8B
| $22.4M | 0.18% |
253,330
+2,844
| +1% | +$234K |
|
139
Public Storage
PSA
$61.5B
| $22.2M | 0.17% |
86,732
-9,319
| -10% | -$2.39M |
|
140
American Tower
AMT
$83.5B
| $21.8M | 0.17% |
191,461
+912
| +0.5% | +$97.1K |
|
141
FedEx
FDX
$73B
| $21.7M | 0.17% |
143,284
+18,121
| +14% | +$2.94M |
|
142
Biogen
BIIB
$30.9B
| $21.6M | 0.17% |
89,363
+2,152
| +2% | +$567K |
|
|
VR
143
DELISTED
Validus Hold Ltd
VR
| $21.6M | 0.17% |
444,169
+66,129
| +17% | +$3.1M |
|
144
Blackrock
BLK
$167B
| $21.5M | 0.17% |
62,889
+2,438
| +4% | +$857K |
|
145
McKesson
MCK
$104B
| $21.4M | 0.17% |
114,543
+11,184
| +11% | +$1.96M |
|
146
Salesforce
CRM
$154B
| $21.3M | 0.17% |
268,056
+30,845
| +13% | +$2.42M |
|
147
Abbott
ABT
$187B
| $21.1M | 0.16% |
536,615
-63,580
| -11% | -$2.53M |
|
148
Adobe
ADBE
$105B
| $21M | 0.16% |
219,124
+11,430
| +6% | +$1.1M |
|
149
Sysco
SYY
$40.8B
| $20.6M | 0.16% |
406,793
+12,296
| +3% | +$595K |
|
150
Exelon
EXC
$48.1B
| $20.2M | 0.16% |
779,802
-107,040
| -12% | -$2.65M |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.